Mylan Institutional, Inc. Provisional
FDA Flags (8)
Class II RecallMar 2025
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablet
Classification: Class II
Class II RecallMar 2025
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets ea
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Classification: Class II
Class II RecallDec 2024
Mylan Institutional, Inc.
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Classification: Class II